An Investigation of Premama Balance and Its Effects on Hormonal Imbalances
NCT ID: NCT05518006
Last Updated: 2024-04-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2022-12-30
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Evaluate the Efficacy of Elix's Cycle Balance and Its Impact on PMS and Menstrual Symptoms
NCT05145257
Study to Evaluate Your Super's Moon Balance and Its Impact on Premenstrual Syndrome
NCT05237661
Effects of a Female Hormone Balance Supplement on Premenstrual Syndrome Symptoms
NCT07018479
A Clinical Trial to Examine the Efficacy of a Supplement to Support Hormone Regulation in Women
NCT06531668
A Single Group Study to Evaluate the Effects of a Supplement on Premenstrual Syndrome
NCT06124326
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PreMama Balance
Each day, the participants will take 1 packet of Premama Balance, dissolved in one glass (8oz+) of water. Premama Balance may be taken with or without food. Should participants present themselves with a sensitive stomach, it is recommended to take the drink with or after a meal to avoid an upset stomach. Participants will repeat this process daily for 6 months/24 weeks (study period) until the study is complete.
At week 12 and in week 24, the participants will take a survey and a hormone test to track progress. In total there will be 3 surveys and 3 hormone tests. Additionally, participants will fill out a weekly consumption survey to track compliance.
PreMama Balance
Premama Balance is a blend of the following: Vitex (Chasteberry Extract), commonly used to help regulate hormones; Antioxidants, Selenium, and Magnesium, also help support the cleansing of hormonal birth control from the liver and help strengthen the uterine lining.
Placebo Drink
Each day, the participants will take 1 packet of Placebo Drink, dissolved in one glass (8oz+) of water. Placebo Drink may be taken with or without food. Should participants present themselves with a sensitive stomach, it is recommended to take the drink with or after a meal to avoid an upset stomach. Participants will repeat this process daily for 6 months/24 weeks (study period) until the study is complete.
At week 12 and in week 24, the participants will take a survey and a hormone test to track progress. In total there will be 3 surveys and 3 hormone tests. Additionally, participants will fill out a weekly consumption survey to track compliance.
Placebo Drink
Blended Placebo drink
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PreMama Balance
Premama Balance is a blend of the following: Vitex (Chasteberry Extract), commonly used to help regulate hormones; Antioxidants, Selenium, and Magnesium, also help support the cleansing of hormonal birth control from the liver and help strengthen the uterine lining.
Placebo Drink
Blended Placebo drink
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must be on hormonal birth control (containing both progesterone and estrogen) for the past 6 months \& willing to stop using it to participate in the study
* Must be willing to get off of hormonal birth control for the study period
* Must be able to track their menstrual cycle
* BMI under 40
* Agree to refrain from any lifestyle changes that may affect their menstrual cycle for the duration of the study
* Willingness to adhere to the dietary supplement regimen
* Willingness to refrain from any other dietary supplements targeting the menstrual cycle and hormone control during the study period
* Is able to communicate in English
* Is willing and able to share feedback via the used technology portal
* Must provide written informed consent (ICF)
Exclusion Criteria
* History of uncontrolled health conditions
* History of hysterectomy or ovariectomy
* History of diabetes \& thyroid disorders
* Smoker
* More than 3 servings of alcohol a day
* Undergoing hormonal therapy of any kind
* Menopausal or peri-menopausal
* Not starting any other form of contraceptive other than condoms, abstinence, planned sexual intercourse
* Usage of any medication or herbal remedies/supplements which can affect the menstrual cycle or hormonal balance
* If currently taking allowed supplements, the dosage needs to remain the same throughout the entirety of the study
20 Years
42 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Citruslabs
INDUSTRY
Premama Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susanne Mitschke
Role: PRINCIPAL_INVESTIGATOR
Citruslabs
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20223
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.